News

Martin Marietta Announces Quarterly Dividend for Shareholders

Martin Marietta Announces Quarterly Dividend for Shareholders

Dividend Announcement and Details

Martin Marietta Materials, Inc. (NYSE: MLM) has made an important announcement regarding its financial commitment to shareholders. The company has declared a quarterly cash dividend of $0.79 per share on its common stock. Shareholders can expect this dividend to be disbursed on March 31 to all those who hold shares by the close of business on March 3.

Company Overview

Based in the United States, Martin Marietta is a prominent name within the S&P 500 Index. It stands out as a leading supplier of essential building materials that include aggregates, cement, ready-mixed concrete, and asphalt. With operations located across 28 states, Canada, and The Bahamas, Martin Marietta plays a critical role in supplying materials necessary for constructing the infrastructure that communities depend on.

Operations and Products

The extensive network of Martin Marietta allows them to deliver high-quality materials essential for building solid foundations. The company’s dedicated teams are committed to supporting infrastructure projects that align with community development and environmental sustainability. Furthermore, the Magnesia Specialties division produces high-purity magnesia and dolomitic lime, which caters to global markets across various sectors including environmental and agricultural applications.

Commitment to Shareholders

Marting Marietta’s regular quarterly dividends signify its dedication to providing value to shareholders while also supporting robust operational growth. This strong dividend policy illustrates the trust the management places in the company’s sustainable financial performance despite fluctuating market conditions.

Investing in the Future

As Martin Marietta continues to grow, the company looks forward to further innovations and expansions. Stakeholders can feel confident knowing that Martin Marietta remains committed to maintaining a favorable capital deployment strategy that benefits not only the company but its shareholders as well. The ability to continue paying dividends is a positive indicator of the company’s financial health.

Contact Information

For further inquiries related to the company or its operations, you can contact:

Jacklyn Rooker
Director, Investor Relations
(919) 510-4736
Jacklyn.Rooker@martinmarietta.com

Frequently Asked Questions

What is the declared dividend amount by Martin Marietta?

The declared cash dividend is $0.79 per share on its common stock.

When will the dividend be paid?

The dividend will be payable on March 31, 2025.

Who is eligible for the dividend?

Shareholders of record by the close of business on March 3, 2025, will be eligible to receive the dividend.

What types of products does Martin Marietta provide?

Martin Marietta supplies aggregates, cement, ready-mixed concrete, asphalt, and environmental products.

How can I get more information about Martin Marietta?

For more information, visit Martin Marietta’s official websites dedicated to their services and products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Darden Faces Class Action Over Reimbursement Failures

Updated Category News Views 251

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 284

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 35

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 176

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 389

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading

Top 5 Most Recently Viewed Articles

Greenwave Technology Solutions CEO Discusses Scrap Metal Growth

Updated Category News Views 153

Greenwave Technology Solutions, Inc. CEO to be Featured on BNN Bloomberg Greenwave Technology Solutions, Inc. (NASDAQ: GWAV) is preparing for a significant media appearance that is set to shed light on the scrap metal industry and its promising future. CEO Danny Meeks is expected to be interviewed on BNN Bloomberg, providing insights into the company’s strategic...

Continue Reading
Exploring China's Transformation: A Look at Progress and Change

Updated Category News Views 207

China isn’t just a big country; it’s a beast that’s undergone an awe-inspiring metamorphosis over the decades. From ancient civilization whispers to a modern superpower roar, this nation has seen changes that make your head spin. As we close in on 75 years since the People's Republic was birthed, China's impressive transformation is undeniable. The China...

Continue Reading
Orion Group Holdings Launches $25 Million Common Stock Offering

Updated Category News Views 41

Orion Group Holdings Announces Public Offering Orion Group Holdings, Inc. (NYSE: ORN) has made a notable announcement about its new public offering of common stock. This move is part of the company's strategy to strengthen its financial base and enhance its operational capabilities in the construction industry. The offering includes 4,860,000 shares priced at $5.15 each,...

Continue Reading
Gaotu Techedu Inc. Set to Reveal Q4 and Fiscal Year Results

Updated Category News Views 109

Gaotu Techedu Inc. to Announce Quarterly Financial Results Gaotu Techedu Inc. (NYSE: GOTU), a prominent education technology company, recently disclosed plans to announce its financial results for the fourth quarter and the entire fiscal year 2024. This announcement will occur before the opening of U.S. markets on February 26. Investors and stakeholders are eager to learn...

Continue Reading
Chicago Atlantic Real Estate Finance Announces Q2 Results Date

Updated Category News Views 116

Chicago Atlantic Real Estate Finance Announces Q2 Earnings Release Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI), a prominent commercial mortgage real estate investment trust, has made significant announcements regarding its upcoming earnings report. Schedule for Earnings Release and Conference Call On a notable date of August 7, the Company plans to release...

Continue Reading